189 related articles for article (PubMed ID: 24022032)
1. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort.
Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I
Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032
[TBL] [Abstract][Full Text] [Related]
2. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
3. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
[TBL] [Abstract][Full Text] [Related]
4. Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
Sleegers K; Brouwers N; Van Damme P; Engelborghs S; Gijselinck I; van der Zee J; Peeters K; Mattheijssens M; Cruts M; Vandenberghe R; De Deyn PP; Robberecht W; Van Broeckhoven C
Ann Neurol; 2009 May; 65(5):603-9. PubMed ID: 19288468
[TBL] [Abstract][Full Text] [Related]
5. Low serum progranulin predicts the presence of mutations: a prospective study.
Schofield EC; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR
J Alzheimers Dis; 2010; 22(3):981-4. PubMed ID: 20858962
[TBL] [Abstract][Full Text] [Related]
6. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
[TBL] [Abstract][Full Text] [Related]
7. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.
Ghidoni R; Benussi L; Glionna M; Franzoni M; Binetti G
Neurology; 2008 Oct; 71(16):1235-9. PubMed ID: 18768919
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
Brouwers N; Nuytemans K; van der Zee J; Gijselinck I; Engelborghs S; Theuns J; Kumar-Singh S; Pickut BA; Pals P; Dermaut B; Bogaerts V; De Pooter T; Serneels S; Van den Broeck M; Cuijt I; Mattheijssens M; Peeters K; Sciot R; Martin JJ; Cras P; Santens P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; Sleegers K
Arch Neurol; 2007 Oct; 64(10):1436-46. PubMed ID: 17923627
[TBL] [Abstract][Full Text] [Related]
9. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
10. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
[TBL] [Abstract][Full Text] [Related]
12. Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia.
Aswathy PM; Jairani PS; Raghavan SK; Verghese J; Gopala S; Srinivas P; Mathuranath PS
Neurobiol Aging; 2016 Mar; 39():218.e1-3. PubMed ID: 26724960
[TBL] [Abstract][Full Text] [Related]
13. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.
López de Munain A; Alzualde A; Gorostidi A; Otaegui D; Ruiz-Martínez J; Indakoetxea B; Ferrer I; Pérez-Tur J; Sáenz A; Bergareche A; Barandiarán M; Poza JJ; Zabalza R; Ruiz I; Urtasun M; Fernández-Manchola I; Olasagasti B; Espinal JB; Olaskoaga J; Ruibal M; Moreno F; Carrera N; Martí Massó JF
Biol Psychiatry; 2008 May; 63(10):946-52. PubMed ID: 17950702
[TBL] [Abstract][Full Text] [Related]
14. Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.
Piscopo P; Rivabene R; Galimberti D; Crestini A; Talarico G; Vanacore N; Scarpini E; Bruno G; Confaloni A
J Alzheimers Dis; 2013; 35(2):313-8. PubMed ID: 23396349
[TBL] [Abstract][Full Text] [Related]
15. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
[TBL] [Abstract][Full Text] [Related]
16. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003
[TBL] [Abstract][Full Text] [Related]
17. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
[TBL] [Abstract][Full Text] [Related]
18. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.
Carecchio M; Fenoglio C; De Riz M; Guidi I; Comi C; Cortini F; Venturelli E; Restelli I; Cantoni C; Bresolin N; Monaco F; Scarpini E; Galimberti D
J Neurol Sci; 2009 Dec; 287(1-2):291-3. PubMed ID: 19683260
[TBL] [Abstract][Full Text] [Related]
19. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration.
Krüger J; Kaivorinne AL; Udd B; Majamaa K; Remes AM
Eur J Neurol; 2009 Jan; 16(1):27-30. PubMed ID: 19049508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
